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The proper development of neuronal circuits during neuromorphogenesis and neuronal-network formation is critically dependent on a
coordinated and intricate series of molecular and cellular cues and responses. Although the cortical actin cytoskeleton is known to play a
key role in neuromorphogenesis, relatively little is known about the specific molecules important for this process. Using linkage analysis
and whole-exome sequencing on samples from families from the Amish community of Ohio, we have demonstrated that mutations in
KPTN, encoding kaptin, cause a syndrome typified bymacrocephaly, neurodevelopmental delay, and seizures. Our immunofluorescence
analyses in primary neuronal cell cultures showed that endogenous and GFP-tagged kaptin associates with dynamic actin cytoskeletal
structures and that this association is lost upon introduction of the identified mutations. Taken together, our studies have identified
kaptin alterations responsible for macrocephaly and neurodevelopmental delay and define kaptin as a molecule crucial for normal
human neuromorphogenesis.Extremes of brain growth have frequently been associated
with impaired neurodevelopment and cognition. Occipi-
tofrontal circumference is an indirect measure of brain
growth and the one most widely used in clinical practice
in which macrocephaly (R2 SDs above the mean) is indic-
ative of brain overgrowth (megalencephaly) in the absence
of hydrocephalus and cranial thickening.1 The differential
diagnosis of macrocephaly relates to the underlying
presence or absence of structural brain anomalies. The
strong association between macrocephaly and neuro-
developmental disability, autism, and other pervasive
developmental disorders is well recognized.2–4 Where
macrocephaly is associated with developmental disability,
there appears to be a significantly increased risk of sei-
zures.4 Over recent years, family studies have begun to
identify gene mutations that might cause inherited forms
of developmental disability. These studies have shed
important new light on the molecular and cellular pro-
cesses that orchestrate the human neuronal circuitry and
that might be dysfunctional in neurological disorders.
The establishment of the incredibly intricate human neu-
ral circuitry is critically dependent upon a complex and
tightly regulated myriad of cellular processes and migra-
tional cues. The actin cytoskeleton is known to play an
important role in the formation, propagation, and steering
of cell motility and migration during brain development.
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tion, which is required for the formation of the complex
functional neuronal networks underlying human higher
brain functions. Mutations in genes encoding molecules
important for normal function of the actin cytoskeleton
have previously been implicated in inherited forms of
developmental disability and brain development,5–7 high-
lighting the important role of the actin cytoskeleton in
neuromorphogenesis.
The studies described here derive from the analysis of
blood samples obtained for DNA extraction (informed
consent was obtained from families from the Anabaptist
communities of Ohio according to protocols approved by
the institutional review board at the University of Arizona
and the Wandsworth Regional Ethics Committee). Nine
family members present in four nuclear families were
affected by an inherited variable form of neurodevelop-
mental delay. The most consistent features were global
developmental delay, macrocephaly with frontal bossing,
high levels of anxiety, and some features suggestive of a
pervasive developmental disorder. Additional features
included craniosynostosis, recurrent pneumonia, and sple-
nomegally. Neuroimaging was performed in four cases,
and no significant intracranial abnormalities were re-
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Figure 1. Family Pedigree and Gene Mapping
(A) Pedigree diagram showing all four investigated nuclear families (families 1–4), which interlink into a single extended family.
Segregation of the two mutations identified (c.776C>A [p.Ser259*] is denoted by X, and c.714_731dup [p.Met241_Gln246dup] is
denoted by Dup) is shown (all genotypings were validated by dideoxy sequence analysis).
(B) Pictorial representation of the SNP genotype data encompassing the chromosome 19 homozygous (solid box) and compound-
heterozygous (dashed box) regions in affected individuals. The locus containing the pathogenic variant is demarcated by SNPs
rs2253022 and rs7246244 (2.59 Mb; families 1 and 2).included frontal bossing, broad nasal tip, scaphocephaly,
hooded eyelids with small, downslanting palpebral fis-
sures, and a prominent chin (Table S1 and Figure S1, avail-
able online).
In order to map the chromosomal location of the patho-
genic variant, we genotyped samples from families 1 and
2 genome-wide by using Illumina Human CytoSNP-12
Beadchip arrays incorporating ~330,000 genetic markers.
A single notable homozygous 2.59 Mb region in
19q.13.32 was found to be shared by all affected individ-
uals in families 1 and 2, although no notable homozygous
regions were detected in affected members of families 3 or
4 (Figures 1A and 1B). Considered likely to harbor the path-
ogenic variant in these families, the homozygous region
identified in families 1 and 2 is delimited by recombinant
SNP markers rs2253022 and rs7246244 and contains 149
genes. Autozygosity across this interval was corroborated
by microsatellite-marker analysis in all family members,
which defined a haplotype cosegregating with the disease
phenotype (data not shown). To identify the causative
mutation, we undertook whole-exome sequence analysis
of a single affected individual (IX:3, Figure 1A) to generate
a profile of variants not present in publically available
databases and rare sequence variants. Coding regions
were captured with a SureSelect Target Enrichment System
(50Mb) and sequencing on a HiSeq system (Illumina) with
76 bp paired-end reads. We obtained 7.6 Gb of reads, of88 The American Journal of Human Genetics 94, 87–94, January 2, 20which 93% had a quality score R 30. Approximately 8%
of the reads were marked as duplicates by Picard (v.1.46)
and were excluded before mapping to the human genome
reference sequence (GRCh37). The Genome Analysis
Toolkit (GATK, v.1.0.5777) was used to realign reads near
potential indel sites and to recalibrate base qualities;
single-nucleotide variants were called with GATK and
SAMtools (v.0.1.16), whereas indels were called with
GATK and Dindel (v.1.01). All variants were annotated
with dbSNP (134) and the 1000 Genomes pilot study
(May 2011) for minor allele frequency. The variant conse-
quences on protein structure were predicted by the Variant
Effect Predictor (VEP v.2.1) with the use of Ensembl (v.63).
Variants were filtered out if the read depth was <43
or >1,2003, if the consensus quality was <20, or if the
SNP quality was <25. After filtering, only one likely delete-
rious variant (g.47983131G>T [NC_000019.9] [c.776C>A
(NM_007059.2); p.Ser259* (NP_008990.2)]) in exon 8 of
KPTN, encoding the 436 amino acid protein kaptin, was
identified within the critical region. The presence of the
variant was confirmed by dideoxy sequencing, which
also confirmed its cosegregation within families 1 and 2
(Figure 1A). Seven heterozygous carriers were identified
in 560 examined control chromosomes, indicating an
allele frequency of approximately 0.012 in this commu-
nity. The variant is also listed in the National Heart,
Lung, and Blood Institute (NHLBI) Exome Sequencing14
Project Exome Variant Server, and one heterozygote has
been reported in 8,285 European American chromosomes.
We next investigated other Amish families with chil-
dren showing similar unexplained developmental delay
associated with macrocephaly, leading to the detection
of the c.776C>A mutation in the heterozygous state in
affected members of 2 of 20 such families (families 3 and
4). Compared with this mutation’s occurrence in Amish
control studies, this frequency was higher than expected,
prompting us to evaluate KPTN for a second mutation
that could be acting in conjunction with the c.776C>A
mutation in these families. Subsequent dideoxy sequence
analysis of all coding regions and associated splice
junctions of KPTN in these families revealed that all
affected children were indeed compound heterozygous
for the c.776C>A variant, as well as an in-frame 18 bp
duplication (g. 47983176_47983193dup [NC_000019.9]
[c.714_731dup (NM_007059.2); p.Met241_Gln246dup
(NP_008990.2)]) in exon 8. Both the c.776C>A and the
c.714_731dup sequence mutations completely cosegregate
with the disease phenotype, as would be expected of
causative compound-heterozygous mutations (Figure 1A,
LODMAX ¼ 10.33 Simwalk28). The c.714_731dup sequence
duplication is not listed in genomic sequence databases,
and one heterozygote was detected in 560 Amish control
chromosomes.
KPTN encodes a largely uncharacterized protein
(Figure S2). Our sequence analyses of kaptin identified no
protein domains or homologous human proteins that
could provide clues to the functional basis of the neurolog-
ical deficits associated with its alteration. We therefore
investigated the expression and localization of kaptin in
neurons. In order to do so, we first cloned human kaptin
from human embryonic kidney 293 cell cDNA obtained
by RNA isolation and RT-PCR as previously described.9
Full-length kaptin (amino acids 1–436) was generated by
PCR using primers BQ2046 (50-AAGAATTCATGATGGGGG
AGGCG-30) and BQ2047 (50-AAGGATCCTTAAGAGGCTG
CATT-30). The PCR product was digested with EcoRI and
BamH1 and cloned in-frame into pEGFP-c2 and subcl-
oned into pCMV-Tag2. Primary rat hippocampal cultures
were prepared and cultured as previously described.10,11
Neurons were transfected with Lipofectamine 2000 (Invi-
trogen) on days 3, 13, and 23 in vitro, fixed in 4% parafor-
maldehyde in PBS for 7 min at room temperature 24 and
48 hr after transfection, and processed for immunofluores-
cence microscopy.12 Confocal imaging was performed
with a Zeiss Axio Observer equipped with ApoTome and
Zeiss Plan-Apochromat 633/1.4 and 403/1.3 objectives
and an AxioCam MRm CCD camera (Zeiss). Primary rat
hippocampal neurons, identifiable by anti-MAP2 immu-
nostaining (Sigma, Abcam), were transfected with wild-
type Flag-tagged kaptin (Flag-kaptin) at DIV3 and imaged
2 days later.Wild-type Flag-kaptin was observed to be local-
ized at F-actin-rich foci in close proximity to the cell bodies
and at growth cones (Figures 2A and 2B, arrow heads). At
later stages of development, when neurons establishedThe Asynapses (DIV14), wild-type Flag-kaptin again colocalized
with F-actin-rich sites. Along dendrites, these sites
appeared mainly to represent F-actin-rich postsynapses,
given that almost all kaptin-enriched puncta were
contacted by presynaptic structures containing bassoon
(a marker for presynaptic active zones) (Figure 2C). To be
able to undertake immunolabeling experiments of endog-
enous kaptin, we first characterized polyclonal rabbit anti-
kaptin (Sigma) in COS-7 cells. Cells expressing wild-type
Flag-kaptin were highlighted by anti-kaptin immuno-
labeling (Figure S3A). Coimmunostaining of primary rat
hippocampal neurons at DIV24 with anti-kaptin and
anti-Shank2 (Neuromab) demonstrated that the dendritic
accumulations of Flag-kaptin at F-actin-rich puncta are
indeed of physiological relevance and reflect the locali-
zation of endogenous kaptin at postsynapses. The vast
majority of anti-kaptin-immunolabeled puncta were not
only enriched with F-actin but were additionally immuno-
positive for Shank2, a postsynaptic scaffold protein inter-
acting with F-actin binding proteins;12,13 Figure 2D).
Kaptin thus appears to be associated with dynamic actin
cytoskeletal structures of neuronal cells. Consistent with
this, wild-type Flag-kaptin accumulated at COS-7 cell
lamellipodia (Figure S3B), the subcellular regions marked
by dense arrays of dynamic actin filaments in mobile fibro-
blasts. In neurons, the cortical actin cytoskeleton is known
to be important for proper neuronal-network formation
during development. Our observations therefore suggest
a role for kaptin in neuromorphogenesis.
The c.776C>A sequence variant is predicted to introduce
a premature stop codon and result in loss of function as
a result of degradation of the mutated transcript by
mRNA-surveillance mechanisms; however, because of a
lack of patient material, we have been unable to confirm
whether a truncated protein (lacking the C-terminal amino
acids 259–436) is produced. In contrast, the in-frame
c.714_731dup mutation is likely to result in the insertion
of six amino acids (Met-Trp-Ser-Val-Leu-Gln) into the full-
length kaptin. In order to investigate the functional
outcome of this mutation, we undertook in silico analysis
of the secondary structural elements of wild-type and
altered kaptin. This revealed that the N-terminal half of
kaptin is likely to comprise a series of relatively densely
organized b sheets, interspersed by only three a helices,
and becomes more a-helical starting with a-helix 4 (span-
ning amino acids 234–245; Figure 3A). Sequence and pre-
dicted structural conservation of both the N-terminal and
C-terminal portions of kaptin are very high even between
evolutionarily distant mammalian species (Figure S2).
Strikingly, duplication of the six amino acids (241–246) is
predicted to disrupt a-helix 4 and result in its conversion
into an extended b sheet (Figure 3C) and is therefore likely
to have a profound effect on kaptin function.
In order to experimentally explore the functionality of
any protein arising from translated mutant transcripts, we
generated both disease-associated GFP-tagged mutants.
We generated the p.Met241_Gln246dup altered kaptinmerican Journal of Human Genetics 94, 87–94, January 2, 2014 89
Figure 2. Kaptin Immunolocalization Studies
(A and B) Flag-kaptin colocalized with F-actin-rich foci at the cell body and in growth cones (examples of both aremarked by arrow heads
in A) in DIV5 rat hippocampal neurons transfected at DIV3. For clarity, the anti-MAP2 immunostaining was omitted from the merged
images. Scale bars represent 10 mm.
(C and D) Endogenous kaptin immunostained together with the presynaptic marker bassoon at DIV14 (C) and with the postsynaptic
marker Shank2 at DIV24 (D). Puncta enrichedwith anti-kaptin immunoreactivity (marked by arrowheads) were rich in F-actin, as shown
by fluorescently labeled phalloidin. (C) Furthermore, they were usually contacted by presynapses. The scale bar represents 5 mm. (D)
Postsynapses marked by Shank2 were largely positive for both F-actin and anti-kaptin immunolabeling (arrow heads). For clarity, the
anti-F-actin staining was omitted from the merged image in (D). High-magnification images are shown. The scale bar represents 2.5 mm.(GFP-kaptinp.Met241_Gln246dup) by fusing an N-terminal
portion carrying the duplication and a SmaI site introduced
as a silent mutation (primers BQ2046 [50-AAGAATTCAT
GATGGGGGAGGCG-30] and BQ2050 [50-TCACCCGGGA
GATGGGCCCGTCTTGCAACACGCTCCACATCTGCAGG
ACCGACCAC-30]) with a C-terminal portion contain-
ing a SmaI site also introduced by silent mutation
(primers BQ2048 [50-ATCTCCCGGGTGATTGTGTTCAG-30]
and BQ2047 [50-AAGGATCCTTAAGAGGCTGCATT-30]).
We generated the p.Ser259* altered kaptin (GFP-
kaptin1–258) by PCR using primers BQ2046 (50-AAGAATTC
ATGATGGGGGAGGCG-30) and BQ2070 (50-AAGTCGAC
CtAGAGGCTGAACAC-30). PCR products were cloned in-
frame intopEGFP-c2.Whereaswild-typeGFP-taggedkaptin
(GFP-kaptin)was found to localize at F-actin-rich lamellipo-
dia ofCOS-7 cells, both altered forms of kaptin displayedno
F-actin association but instead accumulated at irregular
perinuclear sites (Figures 3D–3F). GFP-kaptin1–258 showed
amore pronounced tendency to form such accumulations;
almost all cells were marked with little additional cyto-
plasmic staining outside of these foci. Alternatively, GFP-
kaptinp.Met241_Gln246dup typically displayed fewer and
slightly smaller accumulations; there were slightly higher
levels of cytoplasmatic staining outside of these foci (Fig-90 The American Journal of Human Genetics 94, 87–94, January 2, 20ures 3D–3F). This indicates that both proteins are likely to
benonfunctional, althoughwecannot exclude thepossibil-
ity thatmisfolded altered proteinmight accumulate in neu-
rons of affected individuals and lead to dominant-negative
effects on other neuronal proteins or cell processes.
Finally, because KPTN mutations result primarily in a
form of neurodevelopmental disease, we also analyzed the
behavior of the altered forms of kaptin in primary hippo-
campal neurons during early development. Whereas wild-
typeGFP-kaptinwas again foundtocolocalizewithdynamic
F-actin in growth cones and foci at the cell body, both GFP-
kaptin1–258 and GFP-kaptinp.Met241_Gln246dup were found to
accumulate in a manner reminiscent of the COS-7 studies
in the cell body or at perinuclear sites (Figures 3G–3I).
We investigated anumber of families from theAnabaptist
communities of Ohio and found that multiple individuals
aged 1–30 years were affected by a syndrome in which the
cardinal features include macrocephaly, global develop-
mental delay, behavioral abnormalities, and seizures. Our
molecular studies determined that two distinct founder
mutations affecting the same gene (KPTN, encoding
kaptin), both of which have become entrapped within the
community, are responsible. Compared with individuals
found to be compound heterozygous for p.Ser259*14
Figure 3. Immunolocalization Studies of Altered Kaptin
(A–C) Schematic representation of wild-type human kaptin (A), the truncated p.Ser259* (c.776C>A; GFP-kaptin1–258) (B), and the dupli-
cation (GFP-kaptinp.Met241_Gln246dup) (C). On the left is a graphic overview of secondary structures; b sheets are shown as red boxes, and
a-helices are shown as blue ellipsoids. On the right are amino acids and secondary-structure elements around amino acid 230. a-helix 4 is
predicted to be converted into a b sheet by the insertion of amino acids 241–246, as shown in yellow.
(D–F) Localizations of GFP-kaptin, GFP-kaptin1–258, and GFP-kaptinp.Met241_Gln246dup (green in merges) in COS-7 cells counterstained
with phalloidin (red in merged images). Note that whereas wild-type kaptin was distributed in the cytosol and accumulated at
F-actin-rich lamellipodia (D), both alterations showed accumulations at perinuclear regions (E and F).
(legend continued on next page)
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and p.M241_Q246dup, those individuals found to be
homozygous for the p.Ser259* nonsense alteration ap-
peared to be more severely affected given that they had
a higher incidence of seizures and a greater degree of intel-
lectual impairment. This might indicate that p.Met241_
Gln246dup retains a limited functionality in vivo, and
perhaps consistent with this, we observed that
p.Met241_Gln246dup showed a slightly lesser tendency
than p.Ser259* to form perinuclear accumulations in
our transfection studies. However, the sample cohort is
currently too small for confidently determining any geno-
type-phenotype correlation.
Kaptin is a largely uncharacterized protein originally iso-
lated from human blood platelets but subsequently found
to be expressed in fibroblasts and intestinal and sensory
epithelia.14 A previous study of this molecule suggested a
role at stereocilia tips, and so KPTN was proposed as a
candidate gene for hearing loss.15 However, the affected
individuals described in this study have no evidence of
sensorineural hearing deficits. During development, the
actin cytoskeleton plays a pivotal role in neuronal cell
morphology andmigration, including the generation, pro-
trusion, and steering of growth cones and the formation of
postsynapse and dendritic spines.16–18 Our studies confirm
kaptin expression in neuronal (MAP2-positive) cells. Given
that kaptin was found to localize to F-actin-rich structures,
it is conceivable that loss of kaptin function could either
directly or indirectly lead to impairment of the neuronal
actin cytoskeleton, required for dendritic arborization
and/or spine formation, and result in the disease pheno-
type described. Support for this has been provided by
studies of Rab39B, a small GTPase associated with the
Golgi apparatus;19 alterations in this protein lead to its
downregulation and a concomitant reduction in dendritic
arborization and synapse formation. This was previously
associated with a disease phenotype comprising mental
retardation, epilepsy, and macrocephaly,20,21 features
which overlap with those described here as arising from
kaptin alterations. Similarly, deficiencies of Rho GTPases,
which regulate the actin cytoskeleton by a growing variety
of effector proteins, have been associated with intellectual
disability and defects in spine structure.22–25 Several other
actin-associated proteins, including drebrin A, cortactin,
and Abp1, have also been found to decrease spine density
or formation,26–28 and a growing body of evidence sup-
ports a role for the Arp2/3 complex and directly and indi-
rectly associated proteins in postsynapse formation and
proper development of neuronal morphology.10,11,27,29–38
Our analyses reveal that wild-type kaptin is enriched in
neuronal growth cones and at discrete cortical sites of neu-
rons at early developmental stages. Furthermore, wild-type
kaptin was found to accumulate at postsynapses of neu-(G–I) Transfection of DIV3 rat hippocampal neurons with wild-type a
kaptin was found throughout the cell and showed accumulations at g
In contrast, both alterations accumulated in areas of the cell body (H a
green, MAP2 in red, and phalloidin in blue. Scale bars represent 10 m
92 The American Journal of Human Genetics 94, 87–94, January 2, 20rons undergoing synaptogenesis (DIV14), as indicated by
spatial correlation along dendrites of kaptin accumula-
tions by phalloidin and synaptic-marker immunostaining.
Consistent with this, kaptin was also found to be present
in the postsynapses of mature neurons. The sites demar-
cated by kaptin localization represent areas of high F-actin
content and high actin dynamics. An association between
kaptin and dynamic F-actin was also indicated by the
observed accumulations of Flag-kaptin at the dynamic
lamellipodia as opposed to the more static stress fibers in
COS-7 cells. These observations are consistent with the
suggestion of a lamellipodial localization of kaptin in
chicken embryonic fibroblasts and with the original iso-
lation of kaptin from blood cells with the use of F-actin
columns.14
Taken together, our studies indicate that both of the
identified KPTN mutations are likely to result in loss
of function of kaptin, either by degradation of the mutant
transcript via mRNA-surveillance mechanisms (c.776C>A)
or by the production of mislocalized and/or nonfunc-
tional protein products. These KPTN mutations result
in a distinctive clinical syndrome, and the presence of
macrocephaly combined with global developmental delay
should prompt the diagnostic analysis of KPTN in affected
individuals from Anabaptist communities. The potential
benefits of early diagnosis in this condition are indicated
by the improvement in developmental markers in our
study’s youngest two affected individuals, both of whom
received early and intensive developmental interventions,
although the lack of seizures in these individuals might
also have been beneficial. Finally, our identification of
two KPTN founder mutations within this Anabaptist
population parallels the situation seen for a number of
other genes with multiple mutations that also commonly
cause inherited diseases globally (e.g., GJB2 mutations
in inherited hearing loss, and ATM mutations in ataxia
telangiectasia), indicating that kaptin developmental delay
might be similarly widespread.Supplemental Data
Supplemental Data include four figures and one table and can be
found with this article online at http://www.cell.com/AJHG.Acknowledgments
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